City Holding CO Neurocrine Biosciences Inc Transaction History
City Holding CO
- $675 Million
- Q1 2025
A detailed history of City Holding CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, City Holding CO holds 100 shares of NBIX stock, worth $12,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$12,043
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
645Shares Held
96.3MCall Options Held
312KPut Options Held
311K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$667 Million0.37% of portfolio
-
State Street Corp Boston, MA4.89MShares$589 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$322 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...